ADVAGRAF 5 mg, gélule à libération prolongée

ReimbursedATC L04AD02

Last synced from Base de données publique des médicaments — BDPM (France) on June 3, 2026

Identification

ManufacturerASTELLAS PHARMA EUROPE (PAYS-BAS)

CountryFR (France)

ATC codeL04AD02

Dispensing—

ReimbursedYes

SourceBase de données publique des médicaments — BDPM (France)

Last synced6/3/2026

Packs · 3

cip13
3400938069914
30 plaquettes perforÃ©es unidose PVC PVDC suremballÃ©e(s)/surpochÃ©e(s) aluminium de 1 gÃ©lule(s)
EUR 215.23
cip13
3400949501045
30 plaquette(s) PVC unidose(s) PVDC suremballÃ©e(s)/surpochÃ©e(s) aluminium de 1 gÃ©lule(s) Distributeur parallÃ¨le : BB Farma)
EUR 204.53
cip13
3400949501106
30 plaquettes perforÃ©es unidose PVC PVDC suremballÃ©e(s)/surpochÃ©e(s) aluminium de 1 gÃ©lule(s) (distributeur parallÃ¨le : Difarmed)
EUR 204.53

Annotations

No annotations yet.

Raw payload (JSON)

{
  "cis": "61727612",
  "date_amm": "2007-04-23",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/07/387",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "gélule à libération prolongée",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

Related drugs

Other records sharing ATC code L04AD02.

Access this data programmatically

Query ADVAGRAF 5 mg, gélule à libération prolongée and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.

Get a free API key Read the API docs